Evaluation of liver function by means of serum cytokeratin 18 and hepatocyte growth factor levels in patients with obstructive jaundice

References

• Trauner M, Fickert P, Zollner G, et al. Cellular and molecular mechanisms of cholestasis. In: Blum HE, Maier KP, Sauerbruch T, et al, editors. Liver cirrhosis and its development. Dodrecht (the Netherlands): Kluwer Academic Publishers; 2000. p. 3–20.
   Google Scholar
• Dirlik M, Canbaz H, Düsmez Apa D, et al. The monitoring of progress in apoptosis of liver cells in bile duct-ligated rats. Turk J Gastroenterol. 2009;20:247–256.
   PubMed Web of Science ®Google Scholar
• Lalisang TJ, Sjamsuhidajat R, Siregar NC, et al. Profile of hepatocyte apoptosis and bile lakes before and after bile duct decompression in severe obstructive jaundice patients. Hepatobiliary Pancreat Dis Int. 2010;9:520–523.
   PubMed Web of Science ®Google Scholar
• Wang DS, Dou KF, Li KZ, et al. Hepatocellular apoptosis after hepatectomy in obstructive jaundice in rats. World J Gastroenterol. 2003;9:2737–2741.
   PubMed Web of Science ®Google Scholar
• Yilmaz Y. Systematic review: caspase-cleaved fragments of cytokeratin 18 - the promises and challenges of a biomarker for chronic liver disease. Aliment Pharmacol Ther. 2009;30:1103–1109.
   PubMed Web of Science ®Google Scholar
• Reichen J, Kra¨henbu¨ H, Zimmermann H. Impact of cholestasis on hepatic function: retention of cholephiles and their potential targets. In: Gentilini P, Arias IM, Mclntyre N, et al., editor. Cholestasis. New York: Elsevier Science; 1994. p. 167–175.
   Google Scholar
• Kramer G, Erdal H, Mertens HJ, et al. Differentiation between cell death modes using measurements of different soluble forms of extracellular cytokeratin 18. Cancer Res. 2004;64:1751–1756.
   PubMed Web of Science ®Google Scholar
• Luft T, Conzelmann M, Benner A, et al. Serum cytokeratin-18 fragments as quantitative markers of epithelial apoptosis in liver and intestinal graft-versus-host disease. Blood. 2007;110:4535–4542.
   PubMed Web of Science ®Google Scholar
• Yagmur E, Trautwein C, Leers MP, et al. Elevated apoptosis-associated cytokeratin 18 fragments (CK18Asp386) in serum of patients with chronic liver diseases indicate hepatic and biliary inflammation. Clin Biochem. 2007;40:651–655.
   PubMed Web of Science ®Google Scholar
• Yilmaz Y, Dolar E, Ulukaya E, et al. Elevated serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) in patients with nonalcoholic steatohepatitis and chronic hepatitis C. Med Sci Monit. 2009;39:CR189–CR193.
   Google Scholar
• Papatheodoridis GV, Hadziyannis E, Tsochatzis E, et al. Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection. Gut. 2007;57:500–506.
   PubMed Web of Science ®Google Scholar
• Onodera M, Takikawa Y, Kakisaka K, et al. Differential evaluation of hepatocyte apoptosis and necrosis in acute liver injury. Hepatol Res. 2010;40:605–612.
   PubMed Web of Science ®Google Scholar
• Michalopoulos GK, Zarnegav R. Hepatocyte growth factor. Hepatology. 1992;15:149–155.
   PubMed Web of Science ®Google Scholar
• Makino H, Shimizu H, Ito H, et al. Changes in growth factor and cytokine expression in biliary obstructed rat liver and their relationship with delayed liver regeneration after partial hepatectomy. WJG. 2006; 12:2053–2059.
   PubMed Web of Science ®Google Scholar
• Kosai K, Matsumoto K, Funakoshi H, et al. Hepatocyte growth factor prevents endotoxin-induced lethal hepatic failure in mice. Hepatology. 1999; 30:151–159.
   PubMed Web of Science ®Google Scholar
• Woolbright BL, Antoine DJ, Jenkins RE, et al. Plasma biomarkers of liver injury and inflammation demonstrate a lack of apoptosis during obstructive cholestasis in mice. Toxicol Appl Pharmacol. 2013;273:524–531.
   PubMed Web of Science ®Google Scholar
• Yamano T, Hirai R, Hato S, et al. Delayed liver regeneration with negative regulation of hepatocyte growth factor and positive regulation of transforming growth factor-beta1 mRNA after portal branch ligation in biliary obstructed rats. Surgery. 2002;131:163–171.
   PubMed Web of Science ®Google Scholar
• Lehwald N, Duhme C, Wildner M, et al. HGF and SDF-1-mediated mobilization of CD133+ BMSC for hepatic regeneration following extensive liver resection. Liver Int. 2014;34:89–101.
   PubMed Web of Science ®Google Scholar
• Fang Y, Gurusamy KS, Wang Q, et al. Meta-analysis of randomized clinical trials on safety and efficacy of biliary drainage before surgery for obstructive jaundice. Br J Surg. 2013;100:1589–1596.
   PubMed Web of Science ®Google Scholar